Maharashtra halts COVID vaccination for 18-44 age group, people above 45 to be given priority

0
52


New Delhi: Due to the acute scarcity of COVID-19 vaccines in Maharashtra, the state authorities on Wednesday (May 12) introduced to briefly droop its drive to vaccinate people within the age group of 18 to 44 and divert the accessible inventory of doses for the above-45 age group, Health Minister Rajesh Tope stated. This choice was taken through the state cupboard assembly.

SII unable to present 1.5 crore Covishield vaccines to Maharashtra

 

The minister additionally revealed that the Serum Institute of India (SII) has knowledgeable the Maharashtra authorities that it could be in a position to present 1.5 crore Covishield vaccines to the state solely May 20 onwards. “There is no sufficient supply of vaccine vials by the Centre for inoculation of above-45 age group people. Hence, the state cabinet decided to divert the stock, purchased for the 18-44 age group, for the above-45 age group. Therefore, we are suspending the inoculation of 18-44age group for some period,” Tope stated.

While Covishield vaccine is manufactured by Pune-based SII, Covaxin is produced by Bharat Biotech.

“Adar Poonawalla of SII has informed Chief Minister Uddhav Thackeray of his ability to supply around 1.5 crore vials of Covishield from May 20 onwards. Once we receive the supply, we will resume the vaccination of 18-44 age group,” the minister stated.

On Tuesday, Tope had alleged that the Union authorities was not fulfilling its accountability to present satisfactory variety of vaccine doses to states. 

No Covaxin left, obtained 2.67 lakh doses of Covishield, says Delhi govt

Meanwhile, the Delhi authorities introduced that there’ll be no Covaxin doses accessible at any vaccination centre within the nationwide capital from Wednesday onwards because the inventory has completed, prompting the state authorities to shut round 100 centres. The Delhi authorities, which raised an alarm concerning Covaxin scarcity on May 11 night, stated the final accessible inventory of Covaxin was administered earlier within the day.

“We had just 16,900 doses of Covaxin stock for today (Wednesday) which was administered and we have no Covaxin stock left for any centre. Now, Covaxin will not be administered at any vaccination centre from tomorrow until vaccine supply is received,” stated AAP MLA Atish, whereas giving particulars of the Delhi authorities`s vaccination scheme to the press on Wednesday.

Delhi on Wednesday obtained 2,67,790 doses of Covishield vaccine for people within the 18 to 44 years age group.

Amid the nationwide second wave of the Covid pandemic, the Delhi authorities has been struggling to present beds, oxygen, medicines for Covid sufferers within the hospitals and at houses. For the previous few days, the capital can be struggling for vaccines.

Live TV





Source hyperlink